Lithium use associated with symptom severity in comorbid bipolar disorder I and migraine
- PMID: 35510536
- PMCID: PMC9226809
- DOI: 10.1002/brb3.2585
Lithium use associated with symptom severity in comorbid bipolar disorder I and migraine
Abstract
Introduction: Bipolar disorder (BD) and migraine headaches are frequently comorbid. The common etiological features are unknown, however cortical hyperexcitability (EEG) of migraines, and the report of hyperexcitability in pluripotent stem cell-derived neurons from lithium responsive BD subjects offers a physiological hypothesis of excitable neurons linking these disorders. However, clinical studies suggest that a history of migraine is associated with higher rates of relapse in those with BD taking lithium. Lithium use and history of migraine in this prospective longitudinal study of BD find that lithium use is associated with a greater symptom severity in BD.
Methods: Data on longitudinal outcome from 538 patients with BD I were categorized according to treatment with lithium and comorbidity with migraine. Clinical outcome measures on depression, mania, and quality of life over the most recent 2-year period compared the BD and BD/migraine cohort according to lithium treatment status.
Results: A history of migraines was associated with worse clinical outcomes of depression (p = .002), mania (p = .005), and mental and physical quality of life (p = .004 and p = .005, respectively), independent of lithium use. The BD/migraine cohort treated with lithium was associated with worse symptoms of mania, whereas those without migraine and lithium use were associated with milder manic symptoms (p = .026).
Conclusions: Herein, we replicate the relatively worse outcome in BD with comorbid migraine. We find evidence to suggest that lithium use is associated with more severe symptoms of mania among those with BD and a history of migraine and conclude that lithium is contraindicated in BD comorbid with migraine.
Keywords: bipolar disorder; lithium; mania; migraine.
© 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Conflict of interest statement
Melvin G. McInnis has consulted with Janssen and Otsuka pharmaceuticals, and received research support from Janssen.
Figures


Similar articles
-
Pharmacotherapy in Comorbid Bipolar Disorder and Post-Traumatic Stress Disorder From the STEP-BD Cohort.Bipolar Disord. 2025 Mar;27(2):108-118. doi: 10.1111/bdi.70002. Epub 2025 Feb 14. Bipolar Disord. 2025. PMID: 39953755 Free PMC article.
-
[Antipsychotics in bipolar disorders].Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5. Encephale. 2004. PMID: 15627046 Review. French.
-
[If a patient has never experienced depression, should we tell him he has bipolar disorder? An updated systematic review on recurrent mania].Presse Med. 2019 Nov;48(11 Pt 1):1306-1318. doi: 10.1016/j.lpm.2018.06.020. Epub 2019 Nov 12. Presse Med. 2019. PMID: 31732367 French.
-
Markedly increased prevalence of migraine headaches in adolescents with bipolar disorder.Bipolar Disord. 2021 May;23(3):255-262. doi: 10.1111/bdi.12972. Epub 2020 Jul 16. Bipolar Disord. 2021. PMID: 32609945
-
Impact of comorbid migraine on the clinical course of bipolar disorder.Compr Psychiatry. 2012 Aug;53(6):809-12. doi: 10.1016/j.comppsych.2011.10.006. Epub 2011 Nov 20. Compr Psychiatry. 2012. PMID: 22104557
References
-
- Fornaro, M. , De Berardis, D. , De Pasquale, C. , Indelicato, L. , Pollice, R. , Valchera, A. , Perna, G. , Iasevoli, F. , Tomasetti, C. , Martinotti, G. , Koshy, A. S. , Fasmer, O. B. , & Oedegaard, K. J. (2015). Prevalence and clinical features associated to bipolar disorder‐migraine comorbidity: A systematic review. Comprehensive Psychiatry, 56, 1–16. 10.1016/j.comppsych.2014.09.020 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical